ETFDH and multiple acyl-CoA dehydrogenase deficiency: Importantly, a wide variety of gene ETFDH variants, that encode the flavo-enzyme ETF-ubiquinone oxidoreductase (ETF-QO), have been identified in individuals with late-onset MADD symptoms, many of which can be substantially improved following riboflavin therapy (Table 2).